Skip to content

The effectiveness of multiple atelocollagen injection in partial thickness rotator cuff tear

The effectiveness of multiple atelocollagen injection in partial thickness rotator cuff tear

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004766
Enrollment
40
Registered
2020-02-25
Start date
2020-03-16
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria 1) Adults over 30 and under 70 2) Partial thickness rotator cuff tear diagnosed by imaging test (ultrasound or MRI) 3) Patients who have been treated for more than 3 months by medication or physical therapy but have not improved 4) If the concomitant medication continues to be administered during the trial, patients who have confirmed the correct prescription drug being taken within at least one week and agreed to maintain a constant amount as before injection during the study 5) patients who understand the study, agree to participate in the study, and have their own written consent

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1) Patients with previous history of injection therapy within 6 weeks 2) Patients with Adhesive capsulitis 3) Full thickness rotator cuff tears diagnosed by MRI or ultrasound 4) Patients with a history of uncontrolled diabetes, infectious arthritis, rheumatoid arthritis, tumors, fractures, degenerative arthritis 5) Patients who refuse injection 6) Patients who want surgical treatment 7) Patients with hypersensitivity to collagen 8) Pregnant or lactating or planning to become pregnant 9) Patients expected to have complications because of anticoagulants therapy 10) Patients sensitive to pig protein 11) Patients with a history of radiotherapy and chemotherapy within the past 2 years (except when it is determined that collagen can be administered as judged by a clinician) 12) Patients or family members with autoimmune disease in progress or with past military service 13) Patients who are sensitive to implants 14) Any clinically significant health abnormalities that can affect the completion of the study 15) Patients deemed inappropriate for this study by the judgment of doctor such as mental illness

Design outcomes

Primary

MeasureTime frame
imaging study : shoulder MRI

Secondary

MeasureTime frame
shoulder sonography;shoulder functional score (ASES score, Constant score, KSES score);shoulder range of motion;Pain VAS score

Countries

Korea, Republic of

Contacts

Public Contacthyungseok Park

The Catholic University of Korea, Seoul St. Mary's Hospital

hyungseok929@gmail.com+82-2-2258-6359

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026